Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
23.82
-19.38
-81.36%
Share Warrants & Outstandings
Total Reserve
8.22
-151.81
160.03
105.41%
Shareholder's Funds
12.66
-127.98
140.64
109.89%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.42
80.08
-79.66
-99.48%
Secured Loans
0.42
48.37
-47.95
-99.13%
Unsecured Loans
0.00
31.71
-31.71
-100.00%
Deferred Tax Assets / Liabilities
-0.23
2.99
-3.22
-107.69%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.16
1.78
-1.62
-91.01%
Total Non-Current Liabilities
0.35
37.43
-37.08
-99.06%
Current Liabilities
Trade Payables
3.48
54.74
-51.26
-93.64%
Other Current Liabilities
0.74
3.97
-3.23
-81.36%
Short Term Borrowings
5.37
107.18
-101.81
-94.99%
Short Term Provisions
0.46
0.00
0.46
0.00%
Total Current Liabilities
10.05
165.88
-155.83
-93.94%
Total Liabilities
23.06
75.33
-52.27
-69.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
15.95
103.68
-87.73
-84.62%
Less: Accumulated Depreciation
6.67
66.09
-59.42
-89.91%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
9.28
37.59
-28.31
-75.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.06
0.00
2.06
0.00%
Long Term Loans & Advances
0.53
0.00
0.53
0.00%
Other Non Current Assets
0.04
0.00
0.04
0.00%
Total Non-Current Assets
11.90
37.59
-25.69
-68.34%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.74
18.04
-12.30
-68.18%
Sundry Debtors
5.02
11.95
-6.93
-57.99%
Cash and Bank
0.06
0.13
-0.07
-53.85%
Other Current Assets
0.06
5.73
-5.67
-98.95%
Short Term Loans and Advances
0.28
1.90
-1.62
-85.26%
Total Current Assets
11.16
37.74
-26.58
-70.43%
Net Current Assets (Including Current Investments)
1.11
-128.14
129.25
100.87%
Total Current Assets Excluding Current Investments
11.16
37.74
-26.58
-70.43%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
23.06
75.33
-52.27
-69.39%
Contingent Liabilities
0.11
0.00
0.11
0.00%
Total Debt
5.78
92.42
-86.64
-93.75%
Book Value per share (adjusted)
28.51
-53.72
82.23
153.07%
Annual - Borrowings
Borrowings 5.78 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 9.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024
Annual - Investments
Investments 2.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024
Annual - Current Assets
Current Assets 11.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024






